Skip to main content

Research News


Clinical courses


Clinical research courses

  • Tsetse fly protein provides anti-clotting agent with its own on-off switch

    Researchers at the University of Sydney and University of Geneva have developed a new anticoagulant, whose anticlotting action can be rapidly stopped ‘on demand’. The result could lead to new surgical and post-operative drugs that minimise the risk of serious bleeding.
  • Lower Dose of Mpox Vaccine Is Safe and Generates Six-Week Antibody Response Equivalent to Standard Regimen
    A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six weeks (two weeks after the second dose), according to findings presented today at the European Society of Clinical Microbiology and Infectious Diseases Global Congress in Barcelona. The results suggest that antibody responses contributed to the effectiveness of dose-sparing mpox vaccine regimens used during the 2022 U.S. outbreak.
  • Physical activity in nature helps prevent several diseases, including depression and type 2 diabetes
    Physical activity in natural environments prevent almost 13,000 cases of non-communicable diseases a year in England and save treatment costs of more than 100m pound, new research from the University of Exeter has found.
  • Breast cancer rates rising among Canadian women in their 20s, 30s and 40s
    Researchers highlights need for immediate shift in public health policy as early detection is key to reducing breast cancer death and complications.
  • Use of Acid Reflux Drugs Linked to Higher Risk of Migraine
    People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology®Clinical Practice, an official journal of the American Academy of Neurology.
  • CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial
    CAR T cell therapy has been a highly successful strategy for recurrent or high-risk leukemias or lymphomas, but challenges remain in using this therapy for solid tumors, said first and corresponding author Dr. Meenakshi Hegde, associate professor of pediatrics – hematology and oncology at Baylor and pediatric oncologist at Texas Children’s Cancer Center.
  • Glial Hyper-Drive for Triggering Epileptic Seizures

    Epilepsy, where patients suffer from unexpected seizures, affects roughly 1% of the population. These seizures often involve repetitive and excessive neuronal firing, with the trigger behind this still poorly understood.

  • Key protein regulates immune response to viruses in mammal cells

    Researchers have revealed the regulatory mechanism of a specific protein that plays a key role in balancing the immune response triggered by viral infections in mammal cells. These findings could help drive the development of antiviral therapies and nucleic acid medicines to treat genetic disorders.

  • Transmission of monkey pox associated with genomic changes
    alterations in the monkeypox virus genome that potentially correlate with changes in the virus transmissibility observed in the 2022 outbreak. Monkeypox virus is a double-stranded DNA virus that can infect animals and humans. MPXV causes a disease known as mpox, with symptoms that include fever, swollen lymph nodes, and a rash. Most cases are mild and tend to get better on their own; however, mpox can be very painful and may lead to permanent scarring.
  • Placental Gene responsible for Gestational Diabetes discovered
    A new study led by the Harvard Pilgrim Health Care Institute has identified that a deficit in the placental expression of the gene insulin-like growth factor 1 IGFBP1 and low IGFBP1 circulating levels are associated with insulin resistance during pregnancy, highlighting a potential risk factor for the development of gestational diabetes.
Subscribe to Research News